The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the management of multiple myeloma.
The following sections include:
- Associated ICD-9-CM codes used for the classification of multiple myelomar
- Drugs that have been FDA-approved in the treatment of multiple myeloma
- Drugs that are Compendia listed for off-label use for multiple myeloma based on clinical studies that suggest beneficial use in some cases.
Please note: If a check mark appears in the FDA column it will NOT appear in the Compendia off-label use column - Corresponding HCPCS/CPT® codes and code descriptions